Department of Otorhinolaryngology, Head and Neck Surgery, Philipps-University of Marburg, Marburg, Germany.
Lasers Med Sci. 2010 Jul;25(4):571-6. doi: 10.1007/s10103-010-0762-4. Epub 2010 Mar 9.
We examined the clinical appearance of mucosal venous malformations of the upper aerodigestive tract with regard to their accessibility to laser therapy and further assessed the value of treatment of these lesions with the Nd:YAG and CO(2) lasers. A retrospective study was performed in 50 patients who had undergone laser treatment for mucosal low-flow vascular malformations of the upper aerodigestive tract. Records were reviewed for demographic data, extent of the lesion, treatment modality, required number of therapy sessions and the therapeutic outcome. Follow-up was performed by postinterventional clinical examination and additional interview by phone for current status. Between 1 July 2001 and 30 September 2008 32 women and 18 men received laser treatment and were followed up until 30 June 2009. The lesions were classified into three grades according to their extent and clinical presentation, as follows: grade 1 <2 cm, asymptomatic or mild symptoms; grade 2 2-4 cm, asymptomatic or mild symptoms; and grade 3 > or =4 cm or multiple locations (more than two) or severe symptoms such as dyspnoea, pain or dysphagia. Of the 50 patients, 13 (26%) were classified as having grade 1 disease, 22 (44%) grade 2 disease, and 15 (30%) grade 3 disease. Treatment in 39 patients was solely with the Nd:YAG laser using the noncontact or interstitial technique. Resection using the CO(2) laser was performed in six patients, and combined conventional surgery and Nd:YAG laser therapy in five patients. The applied grading reflects the extent of laser therapy and also the number of therapy sessions performed in patients treated with the Nd:YAG laser. Resection with the CO(2) laser is suitable for grade 1 lesions. In advanced lesions a combined therapeutic approach and multiple sessions are necessary. The Nd:YAG laser is still a valuable therapeutic tool for the treatment of venous malformations of the mucosa.
我们研究了上呼吸道黏膜静脉畸形的临床表现,探讨了其对激光治疗的可及性,并进一步评估了钕:钇铝石榴石(Nd:YAG)激光和二氧化碳(CO2)激光治疗这些病变的价值。对 50 例接受激光治疗上呼吸道黏膜低流量血管畸形的患者进行了回顾性研究。记录了患者的人口统计学数据、病变范围、治疗方式、所需治疗次数以及治疗效果。通过术后临床检查和电话随访了解患者的现状。2001 年 7 月 1 日至 2008 年 9 月 30 日期间,对 32 名女性和 18 名男性患者进行了激光治疗,并随访至 2009 年 6 月 30 日。根据病变范围和临床表现将病变分为三级,如下:Ⅰ级<2cm,无症状或轻度症状;Ⅱ级 2-4cm,无症状或轻度症状;Ⅲ级≥4cm或多个部位(>2 个)或严重症状,如呼吸困难、疼痛或吞咽困难。50 例患者中,13 例(26%)为Ⅰ级疾病,22 例(44%)为Ⅱ级疾病,15 例(30%)为Ⅲ级疾病。39 例患者仅采用 Nd:YAG 激光治疗,采用非接触或介入技术。6 例患者采用 CO2 激光切除术,5 例患者采用联合传统手术和 Nd:YAG 激光治疗。应用分级反映了激光治疗的范围,也反映了采用 Nd:YAG 激光治疗的患者所需治疗次数。CO2 激光切除术适用于Ⅰ级病变。对于晚期病变,需要联合治疗方法和多次治疗。Nd:YAG 激光仍然是治疗黏膜静脉畸形的有效治疗工具。